Effects of Hallucinogens on Neuronal Activity

Lladó-Pelfort, L., Celada, P., Riga, M. S., Troyano-Rodríguez, E., Santana, N., & Artigas, F. | Current Topics in Behavioural Neuroscience | 26 February 2017

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., ... & Vollenweider, F. X. | Current Biology | 26 January 2017

Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion

da Frota Ribeiro, C. M., Sanacora, G., & Ostroff, R. | Biological Psychiatry | 23 January 2017

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

De Gregorio, D., Comai, S., Posa, L., & Gobbi, G. | International Journal of Molecular Sciences | 23 November 2016

A systematic review of the effects of novel psychoactive substances ‘legal highs’ on people with severe mental illness

Gray, R., Bressington, D., Hughes, E., & Ivanecka, A. | Journal of Psychiatric and Mental Health Nursing | 1 April 2016

5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

Wischhof, L., & Koch, M. | Behavioural pharmacology | 19 Aug 2015

Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats.

Grimm, O., Gass, N., Weber-Fahr, W., Sartorius, A., Schenker, E., Spedding, M., ... & Meyer-Lindenberg, A. | Psychopharmacology | 18 July 2015

Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe

Stone, J., Kotoula, V., Dietrich, C., De Simoni, S., Krystal, J. H., & Mehta, M. A. | Journal of Psychopharmacology | 6 July 2015

The use of ketamine for the treatment of depression in the context of psychotic symptoms

da Frota Ribeiro, C. M., Sanacora, G., Hoffman, R., & Ostroff, R. | Biological Psychiatry | 4 June 2015

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

Lebedev, A. V., Lövdén, M., Rosenthal, G., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. | Human brain mapping | 22 May 2015

Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia

Höflich, A., Hahn, A., Küblböck, M., Kranz, G. S., Vanicek, T., Windischberger, C., ... & Guertel, W. | The international journal of neuropsychopharmacology | 20 April 2015

Psychedelics not linked to mental health problems or suicidal behavior: A population study

Johansen, P. Ø., & Krebs, T. S. | Journal of Psychopharmacology | 5 March 2015

Ketamine Users Have High Rates of Psychosis and/or Depression

Liang, H. J., Tang, K. L., Chan, F., Ungvari, G. S., & Tang, W. K. | Journal of addictions nursing | March 2015

Drug models of schizophrenia

Steeds, H., Carhart-Harris, R. L., & Stone, J. M. | Therapeutic Advances in Psychopharmacology | 5 February 2015

Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia

Xu, K., Krystal, J. H., Ning, Y., He, H., Wang, D., Ke, X., ... & Fan, N. | Journal of psychiatric research | February 2015

Editorial (Thematic Issue: Introduction to ‘Beneficial Effects of Psychedelics with a Special Focus on Addictions’)

Kortekaas, R., & Breeksema, J. J. | Current Drug Abuse Reviews | 28 January 2015

Crisis Intervention Related to the Use of Psychoactive Substances in Recreational Settings – Evaluating the Kosmicare Project at Boom Festival

Carvalho, M. C., de Sousa, M. P., Frango, P., Dias, P., Carvalho, J., Rodrigues, M., & Rodrigues, T. | Current Drug Abuse Reviews | 28 January 2015

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., ... & Liechti, M. E. | Biological psychiatry | 29 November 2014

On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis

Grammenos, D., & Barker, S. A. | Journal of Neural Transmission | 2 November 2014

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

Rolland, B., Jardri, R., Amad, A., Thomas, P., Cottencin, O., & Bordet, R. | Biomed Research International | 4 June 2014

Psilocybin – Summary of knowledge and new perspectives

Tylš, F., Páleníček, T., & Horáček, J. | European Neuropsychopharmacology | 17 December 2013

Reviewing the ketamine model for schizophrenia

Frohlich, J., & van Horn, J. D. | Journal of Psychopharmacology | 20 November 2013

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

Carhart-Harris, R. L., Leech, R., Erritzoe, D., Williams, T. M., Stone, J. M., Evans, J., .... Nutt, D. J. | Schizophrenia Bulletin | 8 October 2012

Exploring the impact of ketamine on the experience of illusory body ownership

Morgan, H. L., Turner, D. C., Corlett, P. R., Absalom, A. R., Adapa, R., Arana, F. S., ... Fletcher, P. C. | Biological Psychiatry | 1 January 2011

Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference

Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. | Neuropsychopharmacology Reviews | 22 September 2010